Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
- Analyst Ratings
Upturn AI SWOT - About
AMWL 
American Well Corp (AMWL)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
03/11/2025: AMWL (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
AI Based Fundamental Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Analysis of Past Performance
Type Stock | Historic Profit -73.22% | Avg. Invested days 28 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 03/11/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 106.30M USD | Price to earnings Ratio - | 1Y Target Price 11.64 |
Price to earnings Ratio - | 1Y Target Price 11.64 | ||
Volume (30-day avg) 87378 | Beta 1.23 | 52 Weeks Range 5.00 - 15.26 | Updated Date 04/4/2025 |
52 Weeks Range 5.00 - 15.26 | Updated Date 04/4/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -13.88 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -81.83% | Operating Margin (TTM) -30.79% |
Management Effectiveness
Return on Assets (TTM) -23.97% | Return on Equity (TTM) -53.4% |
Valuation
Trailing PE - | Forward PE - | Enterprise Value -108503573 | Price to Sales(TTM) 0.42 |
Enterprise Value -108503573 | Price to Sales(TTM) 0.42 | ||
Enterprise Value to Revenue 0.73 | Enterprise Value to EBITDA -0.82 | Shares Outstanding 13962700 | Shares Floating 11941798 |
Shares Outstanding 13962700 | Shares Floating 11941798 | ||
Percent Insiders 8.62 | Percent Institutions 48.32 |
Analyst Ratings
Rating 3 | Target Price 11.21 | Buy - | Strong Buy - |
Buy - | Strong Buy - | ||
Hold 9 | Sell - | Strong Sell - | |
Strong Sell - |
Upturn AI SWOT
American Well Corp
Company Overview
History and Background
American Well Corp (Amwell) was founded in 2006 by brothers Ido Schoenberg and Roy Schoenberg. It has evolved from a telehealth provider to a platform enabling healthcare delivery across various modalities.
Core Business Areas
- Amwell Platform: A technology platform enabling healthcare providers and payers to offer telehealth and digital care services.
- Amwell Medical Group: Amwell's own employed physician group providing direct-to-consumer telehealth services.
- Converge: Converge is an interoperable platform that connects provider networks, payers, and patients, enabling seamless digital care experiences.
Leadership and Structure
Amwell is led by CEO Ido Schoenberg. The company has a typical corporate structure with executive leadership, board of directors, and various operational departments.
Top Products and Market Share
Key Offerings
- Amwell Platform: Provides telehealth infrastructure to hospitals, health systems, and payers. Competitors include Teladoc Health, and MDLive. Revenue is derived from subscription fees and usage-based charges, but specific product revenue data is not publicly available. The number of unique users/patients is growing year-over-year, but specific number not public.
- Amwell Medical Group: Direct-to-consumer telehealth consultations with Amwell doctors. Competitors include Teladoc Health and other direct-to-consumer telehealth providers. Revenue for the AMG makes up a portion of the total revenue, but specific revenue figures not available to the public. The number of users is reported in total active users yearly, but specific number not public
- Converge: A platform connecting provider networks, payers, and patients. It competes with other interoperability and care coordination platforms. Early in commercialization, specific market share and revenue not available publicly.
Market Dynamics
Industry Overview
The telehealth industry is experiencing significant growth, driven by increasing demand for remote healthcare services, technological advancements, and regulatory changes. The market is highly competitive with numerous players offering a range of telehealth solutions.
Positioning
Amwell positions itself as a comprehensive telehealth platform provider, catering to both healthcare providers and patients. Its competitive advantages include its established platform, experience in the telehealth market, and broad range of services.
Total Addressable Market (TAM)
The global telehealth market is projected to reach hundreds of billions of dollars in the coming years. Amwell is positioning itself to capture a significant share of this market by offering a platform that supports a wide range of telehealth use cases.
Upturn SWOT Analysis
Strengths
- Established telehealth platform
- Broad range of services
- Experience in the telehealth market
- Partnerships with major healthcare providers
Weaknesses
- Profitability challenges
- Intense competition
- Dependence on regulatory environment
- Relatively high operating costs
- Customer Concentration
Opportunities
- Expanding telehealth adoption
- Growing demand for remote patient monitoring
- Increasing chronic disease management
- Partnerships with payers
- Integration of AI and machine learning
Threats
- Intensifying competition
- Changing regulatory landscape
- Reimbursement challenges
- Data security and privacy concerns
- Potential for commoditization of telehealth services
Competitors and Market Share
Key Competitors
- TDOC
- LVGO
- CVS
- Teladoc Health (TDOC)
- MDLive (CVS)
- Doctor on Demand (Included in Optum Health)
- Optum Health (UNH)
Competitive Landscape
Amwell faces intense competition from larger and more established players in the telehealth market. It needs to differentiate itself through its technology platform and partnerships.
Major Acquisitions
SilverCloud Health
- Year: 2021
- Acquisition Price (USD millions): 230
- Strategic Rationale: Acquisition of SilverCloud Health to expand its behavioral health offerings.
Growth Trajectory and Initiatives
Historical Growth: Amwell experienced growth in telehealth usage during the COVID-19 pandemic. However, growth rates have slowed as the pandemic has subsided.
Future Projections: Analyst estimates suggest continued growth in revenue, but profitability remains a key challenge.
Recent Initiatives: Recent initiatives include partnerships with major healthcare providers and payers, expansion of its platform capabilities, and investments in technology.
Summary
American Well has a solid platform and established partnerships but needs to improve profitability in a very competitive market. Expansion of their customer base is helping to grow their market share, but at the same time, regulatory changes and data privacy concerns are looming threats for them and their competitors. Strategic initiatives are underway to help combat competition, but there are no current indications on a timeline. Investors should watch for progress in the next few years to decide whether the company can sustain profitability or not.
Similar Companies
CVS
CVS Health Corp
CVS
CVS Health Corp
GOOG
Alphabet Inc Class C
GOOG
Alphabet Inc Class C
MSFT
Microsoft Corporation
MSFT
Microsoft Corporation
TDOC
Teladoc Inc
TDOC
Teladoc Inc
UNH
UnitedHealth Group Incorporated
UNH
UnitedHealth Group Incorporated
Sources and Disclaimers
Data Sources:
- Company Filings
- Market Research Reports
- Analyst Estimates
- Press Releases
Disclaimers:
This analysis is based on publicly available information and should not be considered financial advice. Market conditions and company performance are subject to change.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About American Well Corp
Exchange NYSE | Headquaters Boston, MA, United States | ||
IPO Launch date 2020-09-17 | Chairman & CEO Dr. Ido Schoenberg M.D. | ||
Sector Healthcare | Industry Health Information Services | Full time employees 877 | Website https://business.amwell.com |
Full time employees 877 | Website https://business.amwell.com | ||
American Well Corporation, an enterprise platform and software company, delivers digitally enabling hybrid care in the United States and internationally. The company offers Converge, a cloud-based platform that enables health providers, payers, and innovators to provide in-person, virtual and automated care; and delivers virtual primary care, post-discharge follow-up, chronic condition management, virtual nursing, e-sitting, on-demand and scheduled virtual visits, specialty consults, automated care, and behavioral health, as well as offers specialty care programs, including dermatology, musculoskeletal care, second opinion, and cardiometabolic care for patients and members. It also provides Carepoint devices, which transforms proprietary carts, peripherals, tablets, and TVs into digital access points in clinical settings. In addition, the company offers Amwell Medical Group network services consisting of primary and urgent care, behavioral health therapy, lactation counseling, and nutrition services. Further, it provides professional services to facilitate implementation, workflow design, systems integration, and service expansion for its products, as well as patient and provider engagement services. The company sells its products through field sales professionals, channel partners, and value-added resellers. It serves providers, payers, and the government, as well as the higher education sector. American Well Corporation was incorporated in 2006 and is headquartered in Boston, Massachusetts.
Upturn is now on iOS and Android!
Experience Upturn on your mobile. Install it now!
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.